Plunkett Research Online: Fate Therapeutics Inc

FATE THERAPEUTICS INC (FATE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Fate Therapeutics is one of the first biopharmaceutical companies dedicated to discovering and developing pharmacologic modulators of adult stem cells. Fate has an unmatched ability to rigorously interrogate and precisely understand stem cell biology, identifying novel points of pharmacologic interv.....



Fate Therapeutics Inc
Ticker: FATE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 855-875-1800
Fax:
Address: 3535 General Atomics Court
Suite 200
San Diego, CA 92121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Stem Cell & Biotechnology Research & Development
ContactsDescription
J. WolchkoCEO/CFO/Chief Accounting Officer/Director/President
Chris StorgardChief Medical Officer
See More
Fate Therapeutics is one of the first biopharmaceutical companies dedicated to discovering and developing pharmacologic modulators of adult stem cells. Fate has an unmatched ability to rigorously interrogate and precisely understand stem cell biology, identifying novel points of pharmacologic interv.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: